Smaller Pill Packs a Priority for FDA

President Donald Trump is planning on signing bipartisan bill H.R. 6 into law next week. When this happens, the new legislation will be going into effect the week of October 22, according to Scott Gottlieb, the FDA commissioner, who recently spoke at a Politico event. The first thing his agency wants to tackle? Creating smaller pill packaging for opioids, in hopes that it will prevent people from abusing their prescriptions for acute pain.

The legislation affects Purdue Pharma, Johnson & Johnson, and other large opioid manufacturers. It will force them to create new packaging for the drug to accommodate small quantities. The provision is an effort to prevent excess pills from being prescribed. With this policy, doctors may prescribe more limited amounts of pills. This could also prevent people from keeping leftover opioids around.

“The first thing that we’re …

Continue ReadingSmaller Pill Packs a Priority for FDA

House Will Vote to Potentially Ban Kratom, Synthetics

The House of Representatives faces nearly two dozen votes on new drug-related bills in an effort to stem the addiction epidemic. Among those bills is H.R. 2851, The Stop Importation and Trafficking of Synthetic Analogues (SITSA) Act, a bill aimed at Kratom and other synthetic drug imports, even those that have not been created yet.

The bill, if passed and made into law, will significantly expand the powers of the Department of Justice, under the guise of unilaterally prohibiting any synthetic drugs the DOJ decides is chemically similar to currently banned drugs. People who import such drugs would face similar penalties to people who import substances that are alreadu banned.

While the measure may have been proposed with good intentions, critics say that if passed, a new era will be entered in the War on Drugs, and it may cause …

Continue ReadingHouse Will Vote to Potentially Ban Kratom, Synthetics